Literature DB >> 22231784

Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis.

Yang Liu1, Daizhan Zhou1, Fang Zhang1, Yanyang Tu1, Yulei Xia1, Hui Wang1, Ben Zhou1, Yi Zhang1, Jingxia Wu1, Xiang Gao2, Zhishui He1, Qiwei Zhai3.   

Abstract

Patt1 is a newly identified protein acetyltransferase that is highly expressed in liver. However, the role of Patt1 in liver is still unclear. We generated Patt1 liver-specific knockout (LKO) mice and mainly measured the effect of hepatic Patt1 deficiency on lipid metabolism. Hepatic Patt1 deficiency in male mice markedly decreases fat mass and dramatically alleviates age-associated accumulation of lipid droplets in liver. Moreover, hepatic Patt1 abrogation in male mice significantly reduces the liver triglyceride and free fatty acid levels, but it has no effect on liver cholesterol level, liver weight, and liver function. Consistently, primary cultured Patt1-deficient hepatocytes are resistant to palmitic acid-induced lipid accumulation, but hepatic Patt1 deficiency fails to protect male mice from high-fat diet-induced hepatic steatosis. Further studies show that hepatic Patt1 deficiency decreases fatty acid uptake, reduces lipid synthesis, and enhances fatty acid oxidation, which may contribute to the attenuated hepatic steatosis in Patt1 LKO mice. These results demonstrate that Patt1 plays an important role in hepatic lipid metabolism and have implications toward resolving age-associated hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231784      PMCID: PMC3276459          DOI: 10.1194/jlr.M019257

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

1.  Wnt signaling regulates hepatic metabolism.

Authors:  Hongjun Liu; Maria M Fergusson; J Julie Wu; Ilsa I Rovira; Jie Liu; Oksana Gavrilova; Teng Lu; Jianjun Bao; Donghe Han; Michael N Sack; Toren Finkel
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

2.  Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes.

Authors:  Karen Mathijs; Anne S Kienhuis; Karen J J Brauers; Danyel G J Jennen; Agustin Lahoz; Jos C S Kleinjans; Joost H M van Delft
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

3.  Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required?

Authors:  Bianca M Arendt; Johane P Allard
Journal:  Am J Gastroenterol       Date:  2011-01       Impact factor: 10.864

4.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

Authors:  Julien Bricambert; Jonatan Miranda; Fadila Benhamed; Jean Girard; Catherine Postic; Renaud Dentin
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

Review 5.  Regulation of intermediary metabolism by protein acetylation.

Authors:  Kun-Liang Guan; Yue Xiong
Journal:  Trends Biochem Sci       Date:  2010-10-08       Impact factor: 13.807

6.  Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.

Authors:  Qiong Wang; Lei Jiang; Jue Wang; Shoufeng Li; Yue Yu; Jia You; Rong Zeng; Xiang Gao; Liangyou Rui; Wenjun Li; Yong Liu
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 7.  Current treatment of non-alcoholic fatty liver disease.

Authors:  Mohamed H Ahmed; Christopher D Byrne
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

8.  PCAF acetylates {beta}-catenin and improves its stability.

Authors:  Xinjian Ge; Qihuang Jin; Fang Zhang; Tingting Yan; Qiwei Zhai
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

9.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

Authors:  Aparna Purushotham; Thaddeus T Schug; Qing Xu; Sailesh Surapureddi; Xiumei Guo; Xiaoling Li
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

10.  A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.

Authors:  Chris Church; Sheena Lee; Eleanor A L Bagg; James S McTaggart; Robert Deacon; Thomas Gerken; Angela Lee; Lee Moir; Jasmin Mecinović; Mohamed M Quwailid; Christopher J Schofield; Frances M Ashcroft; Roger D Cox
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more
  15 in total

1.  The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy.

Authors:  Shuxian Dong; Caifeng Jia; Shengping Zhang; Guangjian Fan; Yubing Li; Peipei Shan; Lianhui Sun; Wenzhen Xiao; Lei Li; Yi Zheng; Jinqin Liu; Haibing Wei; Chen Hu; Wen Zhang; Y Eugene Chin; Qiwei Zhai; Qiao Li; Jian Liu; Fuli Jia; Qianxing Mo; Dean P Edwards; Shixia Huang; Lawrence Chan; Bert W O'Malley; Xiaotao Li; Chuangui Wang
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

2.  The molecular basis for histone H4- and H2A-specific amino-terminal acetylation by NatD.

Authors:  Robert S Magin; Glen P Liszczak; Ronen Marmorstein
Journal:  Structure       Date:  2015-01-22       Impact factor: 5.006

3.  Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice.

Authors:  Jibran A Wali; Sandra Galic; Christina Yr Tan; Esteban N Gurzov; Ann E Frazier; Timothy Connor; Jingjing Ge; Evan G Pappas; David Stroud; L Chitra Varanasi; Claudia Selck; Michael T Ryan; David R Thorburn; Bruce E Kemp; Balasubramanian Krishnamurthy; Thomas Wh Kay; Sean L McGee; Helen E Thomas
Journal:  Cell Death Differ       Date:  2017-10-20       Impact factor: 15.828

4.  Loss of Nat4 and its associated histone H4 N-terminal acetylation mediates calorie restriction-induced longevity.

Authors:  Diego Molina-Serrano; Vassia Schiza; Christis Demosthenous; Emmanouil Stavrou; Jan Oppelt; Dimitris Kyriakou; Wei Liu; Gertrude Zisser; Helmut Bergler; Weiwei Dang; Antonis Kirmizis
Journal:  EMBO Rep       Date:  2016-10-31       Impact factor: 8.807

5.  NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.

Authors:  Junyi Ju; Aiping Chen; Yexuan Deng; Ming Liu; Ying Wang; Yadong Wang; Min Nie; Chao Wang; Hong Ding; Bing Yao; Tao Gui; Xinyu Li; Zhen Xu; Chi Ma; Yong Song; Marc Kvansakul; Ke Zen; Chen-Yu Zhang; Cheng Luo; Ming Fang; David C S Huang; C David Allis; Renxiang Tan; Changjiang Kathy Zeng; Jiwu Wei; Quan Zhao
Journal:  Nat Commun       Date:  2017-10-13       Impact factor: 14.919

6.  Hemin Improves Insulin Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet.

Authors:  Yi Luan; Fang Zhang; Yalan Cheng; Jun Liu; Rui Huang; Menghong Yan; Yuangao Wang; Zhishui He; Hejin Lai; Hui Wang; Hao Ying; Feifan Guo; Qiwei Zhai
Journal:  Nutrients       Date:  2017-07-26       Impact factor: 5.717

7.  Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway.

Authors:  Yu-Yao Zhang; Chao Li; Gao-Feng Yao; Lin-Juan Du; Yuan Liu; Xiao-Jun Zheng; Shuai Yan; Jian-Yong Sun; Yan Liu; Ming-Zhu Liu; Xiaoran Zhang; Gang Wei; Wenxin Tong; Xiaobei Chen; Yong Wu; Shuyang Sun; Suling Liu; Qiurong Ding; Ying Yu; Huiyong Yin; Sheng-Zhong Duan
Journal:  Diabetes       Date:  2017-03-21       Impact factor: 9.461

Review 8.  Histone N-alpha terminal modifications: genome regulation at the tip of the tail.

Authors:  Christina Demetriadou; Costas Koufaris; Antonis Kirmizis
Journal:  Epigenetics Chromatin       Date:  2020-07-17       Impact factor: 4.954

9.  N-alpha-terminal acetylation of histone H4 regulates arginine methylation and ribosomal DNA silencing.

Authors:  Vassia Schiza; Diego Molina-Serrano; Dimitris Kyriakou; Antonia Hadjiantoniou; Antonis Kirmizis
Journal:  PLoS Genet       Date:  2013-09-19       Impact factor: 5.917

10.  Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathway.

Authors:  Demetria Pavlou; Antonis Kirmizis
Journal:  Apoptosis       Date:  2016-03       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.